Accelsiors has announced the opening of a new office in Gurgaon, India. This investment will provide our biotechnology, pharmaceutical and medical device customers with greater access to patient populations in an increasingly well-regulated environment.
“Accelsiors is committed to providing our customers with a depth of medical, scientific and regulatory expertise while conducting clinical studies with utmost quality,” said Mihaly Juhasz, M.D., Accelsiors’ CEO. “Our 20 years of experience in the biosimilar sector and ability to provide stand-alone services (biometrics) has driven us to make this important investment.”
The Asian biosimilar development market is growing at a rapid pace and Accelsiors is now positioned to provide an even greater level of support to current and prospective customers. Additionally, the added headcount enables us to provide a quality-driven, scalable solution to functional service provision, specifically biometrics.
“We are honored to be a part of Accelsiors global expansion,” said Shabbir Rangwala, vice president, Operations. “Not only will Accelsiors be creating new jobs in India, but the expansion represents a renewed level of confidence in the quality of service delivery in the region.”
As the leader of the Asian Operations Team, Rangwala will oversee local operations while establishing and executing strategic growth strategies across the region.
Accelsiors is a scientifically-driven CRO committed to serving the needs of its sponsors with the highest level of quality.